526 related articles for article (PubMed ID: 36932414)
1. Cryptococcus neoformans, a global threat to human health.
Zhao Y; Ye L; Zhao F; Zhang L; Lu Z; Chu T; Wang S; Liu Z; Sun Y; Chen M; Liao G; Ding C; Xu Y; Liao W; Wang L
Infect Dis Poverty; 2023 Mar; 12(1):20. PubMed ID: 36932414
[TBL] [Abstract][Full Text] [Related]
2. Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients.
Pfaller M; Zhang J; Messer S; Tumberland M; Mbidde E; Jessup C; Ghannoum M
Diagn Microbiol Infect Dis; 1998 Nov; 32(3):191-9. PubMed ID: 9884835
[TBL] [Abstract][Full Text] [Related]
3. An Antivirulence Approach for Preventing Cryptococcus neoformans from Crossing the Blood-Brain Barrier via Novel Natural Product Inhibitors of a Fungal Metalloprotease.
Aaron PA; Vu K; Gelli A
mBio; 2020 Jul; 11(4):. PubMed ID: 32694141
[No Abstract] [Full Text] [Related]
4. Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal Disease.
Nixon GL; McEntee L; Johnson A; Farrington N; Whalley S; Livermore J; Natal C; Washbourn G; Bibby J; Berry N; Lestner J; Truong M; Owen A; Lalloo D; Charles I; Hope W
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29311092
[TBL] [Abstract][Full Text] [Related]
5. Cryptococcal meningitis.
Tugume L; Ssebambulidde K; Kasibante J; Ellis J; Wake RM; Gakuru J; Lawrence DS; Abassi M; Rajasingham R; Meya DB; Boulware DR
Nat Rev Dis Primers; 2023 Nov; 9(1):62. PubMed ID: 37945681
[TBL] [Abstract][Full Text] [Related]
6. Comparison of clinical and biological characteristics of HIV-infected patients presenting Cryptococcus neoformans versus C. curvatus/C. laurentii meningitis.
Zono B; Moutschen M; Situakibanza H; Sacheli R; Muendele G; Kabututu P; Biakabuswa A; Landu N; Mvumbi G; Hayette MP
BMC Infect Dis; 2021 Nov; 21(1):1157. PubMed ID: 34781895
[TBL] [Abstract][Full Text] [Related]
7. Cryptococcal meningitis due to Cryptococcus neoformans genotype AFLP1/VNI in Iran: a review of the literature.
Badali H; Alian S; Fakhim H; Falahatinejad M; Moradi A; Mohammad Davoudi M; Hagen F; Meis JF
Mycoses; 2015 Dec; 58(12):689-93. PubMed ID: 26444438
[TBL] [Abstract][Full Text] [Related]
8. Resistance and Tolerance to Cryptococcal Infection: An Intricate Balance That Controls the Development of Disease.
Shourian M; Qureshi ST
Front Immunol; 2019; 10():66. PubMed ID: 30761136
[No Abstract] [Full Text] [Related]
9. Physiological Differences in Cryptococcus neoformans Strains
Grossman NT; Casadevall A
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031206
[No Abstract] [Full Text] [Related]
10. Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance.
Hope W; Stone NRH; Johnson A; McEntee L; Farrington N; Santoro-Castelazo A; Liu X; Lucaci A; Hughes M; Oliver JD; Giamberardino C; Mfinanga S; Harrison TS; Perfect JR; Bicanic T
mBio; 2019 Dec; 10(6):. PubMed ID: 31796539
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of the antifungal effect of sertraline in the treatment of cryptococcal meningitis in HIV patients: a single Mexican center experience.
Villanueva-Lozano H; Treviño-Rangel RJ; González GM; Hernández-Rodríguez PA; Camacho-Ortiz A; Castillo-Reyna L; Galindo-Alvarado SG; Martínez-Reséndez MF
Infection; 2018 Feb; 46(1):25-30. PubMed ID: 28815430
[TBL] [Abstract][Full Text] [Related]
12. A titanic drug resistance threat in Cryptococcus neoformans.
Zafar H; Altamirano S; Ballou ER; Nielsen K
Curr Opin Microbiol; 2019 Dec; 52():158-164. PubMed ID: 31765991
[TBL] [Abstract][Full Text] [Related]
13. A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease.
Chau TT; Mai NH; Phu NH; Nghia HD; Chuong LV; Sinh DX; Duong VA; Diep PT; Campbell JI; Baker S; Hien TT; Lalloo DG; Farrar JJ; Day JN
BMC Infect Dis; 2010 Jul; 10():199. PubMed ID: 20618932
[TBL] [Abstract][Full Text] [Related]
14. Fungal CNS Infections in Africa: The Neuroimmunology of Cryptococcal Meningitis.
Mohamed SH; Nyazika TK; Ssebambulidde K; Lionakis MS; Meya DB; Drummond RA
Front Immunol; 2022; 13():804674. PubMed ID: 35432326
[TBL] [Abstract][Full Text] [Related]
15. Symptomatic relapse of HIV-associated cryptococcal meningitis: recurrent cryptococcal meningitis or Cryptococcus-related immune reconstitution inflammatory syndrome?
Jhamb R; Kashyap B; Das S; Berry N; Garg A
Int J STD AIDS; 2014 Apr; 25(5):369-72. PubMed ID: 24108453
[TBL] [Abstract][Full Text] [Related]
16. Experimental Evolution of Antifungal Resistance in Cryptococcus neoformans.
Bermas A; Geddes-McAlister J
Curr Protoc Microbiol; 2020 Dec; 59(1):e116. PubMed ID: 32986290
[TBL] [Abstract][Full Text] [Related]
17. An Atypical ABC Transporter Is Involved in Antifungal Resistance and Host Interactions in the Pathogenic Fungus Cryptococcus neoformans.
Winski CJ; Qian Y; Mobashery S; Santiago-Tirado FH
mBio; 2022 Aug; 13(4):e0153922. PubMed ID: 35726920
[TBL] [Abstract][Full Text] [Related]
18. Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain.
Gago S; Serrano C; Alastruey-Izquierdo A; Cuesta I; Martín-Mazuelos E; Aller AI; Gómez-López A; Mellado E
Mycoses; 2017 Jan; 60(1):40-50. PubMed ID: 27633849
[TBL] [Abstract][Full Text] [Related]
19. Treatment for HIV-associated cryptococcal meningitis.
Tenforde MW; Shapiro AE; Rouse B; Jarvis JN; Li T; Eshun-Wilson I; Ford N
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD005647. PubMed ID: 30045416
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and management of cryptococcal meningitis: developments and challenges.
Pukkila-Worley R; Mylonakis E
Expert Opin Pharmacother; 2008 Mar; 9(4):551-60. PubMed ID: 18312157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
